ID

37442

Descripción

A Phase II Trial of a Protease Inhibitor, Nelfinavir (NFV), Given With Definitive, Concurrent Chemoradiotherapy (CTRT) in Patients With Locally-Advanced, Human Papilloma Virus (HPV) Negative, Squamous Cell Carcinoma Larynx; ODM derived from: https://clinicaltrials.gov/show/NCT02207439

Link

https://clinicaltrials.gov/show/NCT02207439

Palabras clave

Versiones (1)
  1. 26/7/19 26/7/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

26 de julio de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Stage III, IVa, or IVb Squamous Cell Carcinoma of the Larynx, With ECOG Performance Status 0-2 NCT02207439

Inglés

Eligibility Stage III, IVa, or IVb Squamous Cell Carcinoma of the Larynx, With ECOG Performance Status 0-2 NCT02207439

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
stage iii, iva, or ivb squamous cell carcinoma of the larynx, with ecog performance status 0-2
Descripción

Laryngeal Squamous Cell Carcinoma TNM clinical staging | ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0280324
UMLS CUI [1,2]
C3258246
UMLS CUI [2]
C1520224
patients 18 years or older.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
determined by the treating physician to be a candidate for organ preserving, concurrent standard chemotherapy and radiation therapy to the head and neck with definitive intent.
Descripción

Patient Appropriate Organ Preserving | Chemotherapy Head and neck | Radiotherapy to head and neck

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548787
UMLS CUI [1,3]
C0178784
UMLS CUI [1,4]
C0728887
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0460004
UMLS CUI [3]
C3888854
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior radiation therapy to the head and neck prior chemotherapy within the past 5 years
Descripción

Prior radiation therapy Head and neck | Prior Chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0279134
UMLS CUI [1,2]
C0460004
UMLS CUI [2]
C1514457
previous therapy with a human immunodeficiency virus (hiv) protease inhibitor presence of t4b disease,precluding organ preservation pregnant or lactating patients. patients with known hiv disease.
Descripción

HIV Protease Inhibitor | Disease TNM clinical staging | Pregnancy | Breast Feeding | HIV Infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3536912
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C3258246
UMLS CUI [3]
C0032961
UMLS CUI [4]
C0006147
UMLS CUI [5]
C0019693
these patients have a high probability of treatment with anti-retroviral therapy which may interact with the nelfinavir.
Descripción

Antiretroviral therapy Interaction Nelfinavir

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1963724
UMLS CUI [1,2]
C0687133
UMLS CUI [1,3]
C0525005
absolute neutrophil count 1500 per mm3 platelet count 100,000 per mm3 serum creatinine 1.5 times the upper limit of normal serum ast or alt 2 times the upper limit of normal
Descripción

Absolute neutrophil count | Platelet Count measurement | Serum creatinine raised | Aspartate aminotransferase increased | Alanine aminotransferase increased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0700225
UMLS CUI [4]
C0151904
UMLS CUI [5]
C0151905
serum bilirubin 1.2 mg/dl weight loss of 10% over the past 6 months which is due to tumor wasting syndrome distant metastases patients receiving the following drugs that are contraindicated with nfv will be excluded.
Descripción

Serum bilirubin measurement | Weight loss Percentage Timespan | Etiology Malignant Neoplasm | Wasting Syndrome | Distant metastasis | Pharmaceutical Preparations Contraindicated Nelfinavir

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0428441
UMLS CUI [2,1]
C1262477
UMLS CUI [2,2]
C0439165
UMLS CUI [2,3]
C0872291
UMLS CUI [3,1]
C0015127
UMLS CUI [3,2]
C0006826
UMLS CUI [4]
C0043046
UMLS CUI [5]
C1269798
UMLS CUI [6,1]
C0013227
UMLS CUI [6,2]
C1444657
UMLS CUI [6,3]
C0525005
Volver a la parte superior de la página

Similar models

Eligibility Stage III, IVa, or IVb Squamous Cell Carcinoma of the Larynx, With ECOG Performance Status 0-2 NCT02207439

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Laryngeal Squamous Cell Carcinoma TNM clinical staging | ECOG performance status
Item
stage iii, iva, or ivb squamous cell carcinoma of the larynx, with ecog performance status 0-2
boolean
C0280324 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C1520224 (UMLS CUI [2])
Age
Item
patients 18 years or older.
boolean
C0001779 (UMLS CUI [1])
Patient Appropriate Organ Preserving | Chemotherapy Head and neck | Radiotherapy to head and neck
Item
determined by the treating physician to be a candidate for organ preserving, concurrent standard chemotherapy and radiation therapy to the head and neck with definitive intent.
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0178784 (UMLS CUI [1,3])
C0728887 (UMLS CUI [1,4])
C0392920 (UMLS CUI [2,1])
C0460004 (UMLS CUI [2,2])
C3888854 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Prior radiation therapy Head and neck | Prior Chemotherapy
Item
prior radiation therapy to the head and neck prior chemotherapy within the past 5 years
boolean
C0279134 (UMLS CUI [1,1])
C0460004 (UMLS CUI [1,2])
C1514457 (UMLS CUI [2])
HIV Protease Inhibitor | Disease TNM clinical staging | Pregnancy | Breast Feeding | HIV Infection
Item
previous therapy with a human immunodeficiency virus (hiv) protease inhibitor presence of t4b disease,precluding organ preservation pregnant or lactating patients. patients with known hiv disease.
boolean
C3536912 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C0032961 (UMLS CUI [3])
C0006147 (UMLS CUI [4])
C0019693 (UMLS CUI [5])
Antiretroviral therapy Interaction Nelfinavir
Item
these patients have a high probability of treatment with anti-retroviral therapy which may interact with the nelfinavir.
boolean
C1963724 (UMLS CUI [1,1])
C0687133 (UMLS CUI [1,2])
C0525005 (UMLS CUI [1,3])
Absolute neutrophil count | Platelet Count measurement | Serum creatinine raised | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
absolute neutrophil count 1500 per mm3 platelet count 100,000 per mm3 serum creatinine 1.5 times the upper limit of normal serum ast or alt 2 times the upper limit of normal
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0700225 (UMLS CUI [3])
C0151904 (UMLS CUI [4])
C0151905 (UMLS CUI [5])
Serum bilirubin measurement | Weight loss Percentage Timespan | Etiology Malignant Neoplasm | Wasting Syndrome | Distant metastasis | Pharmaceutical Preparations Contraindicated Nelfinavir
Item
serum bilirubin 1.2 mg/dl weight loss of 10% over the past 6 months which is due to tumor wasting syndrome distant metastases patients receiving the following drugs that are contraindicated with nfv will be excluded.
boolean
C0428441 (UMLS CUI [1])
C1262477 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0872291 (UMLS CUI [2,3])
C0015127 (UMLS CUI [3,1])
C0006826 (UMLS CUI [3,2])
C0043046 (UMLS CUI [4])
C1269798 (UMLS CUI [5])
C0013227 (UMLS CUI [6,1])
C1444657 (UMLS CUI [6,2])
C0525005 (UMLS CUI [6,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial